BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen W, Jiang J, Gong L, Shu Z, Xiang D, Zhang X, Bi K, Diao H. Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a FOXO3/miRNA-30b-5p/MINPP1 axis. J Exp Clin Cancer Res 2021;40:1. [PMID: 33390177 DOI: 10.1186/s13046-020-01803-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Singh M, Bindal G, Misra CS, Rath D. The era of Cas12 and Cas13 CRISPR-based disease diagnosis. Crit Rev Microbiol 2022;:1-16. [PMID: 35164636 DOI: 10.1080/1040841X.2021.2025041] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ning Z, Yu S, Zhao Y, Sun X, Wu H, Yu X. Identification of miRNA-Mediated Subpathways as Prostate Cancer Biomarkers Based on Topological Inference in a Machine Learning Process Using Integrated Gene and miRNA Expression Data. Front Genet 2021;12:656526. [PMID: 33841512 DOI: 10.3389/fgene.2021.656526] [Reference Citation Analysis]
3 Zhao J, Wang Y, Su H, Su L. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review. Clin Res Hepatol Gastroenterol 2021;45:101736. [PMID: 34146723 DOI: 10.1016/j.clinre.2021.101736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jiang Y, Han Q, Zhao H, Zhang J. The Mechanisms of HBV-Induced Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:435-50. [PMID: 34046368 DOI: 10.2147/JHC.S307962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Dong Z, Chang X, Xie L, Wang Y, Hou Y. Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma. Bioengineered 2022;13:6100-12. [PMID: 35192432 DOI: 10.1080/21655979.2022.2034705] [Reference Citation Analysis]
6 Xu G, Yang Z, Sun Y, Dong H, Ma J. Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer. Discov Onc 2021;12. [DOI: 10.1007/s12672-021-00430-9] [Reference Citation Analysis]
7 Yu L, Fu J, Shen C. Ubiquitin specific peptidase 47 promotes proliferation of lung squamous cell carcinoma. Genes Genomics 2022;44:721-31. [PMID: 35254655 DOI: 10.1007/s13258-022-01233-0] [Reference Citation Analysis]
8 Ren Z, Yu Y, Chen C, Yang D, Ding T, Zhu L, Deng J, Xu Z. The Triangle Relationship Between Long Noncoding RNA, RIG-I-like Receptor Signaling Pathway, and Glycolysis. Front Microbiol 2021;12:807737. [PMID: 34917069 DOI: 10.3389/fmicb.2021.807737] [Reference Citation Analysis]
9 Zuo Z, Li Y, Zeng C, Xi Y, Tao H, Guo Y. Integrated Analyses Identify Key Molecules and Reveal the Potential Mechanism of miR-182-5p/FOXO1 Axis in Alcoholic Liver Disease. Front Med (Lausanne) 2021;8:767584. [PMID: 34950682 DOI: 10.3389/fmed.2021.767584] [Reference Citation Analysis]
10 Song Y, Gao Z, Yan Z, Zheng C. Tripartite Motif Containing 3 inhibits the aggressive behaviors of papillary thyroid carcinoma and indicates lower recurrence risk. Genes Genomics 2021. [PMID: 34860317 DOI: 10.1007/s13258-021-01197-7] [Reference Citation Analysis]
11 Jiang J, Li Y, Sun Z, Gong L, Li X, Shi F, Yao J, Meng Y, Meng X, Zhang Q, Wang Y, Su X, Diao H. LncNSPL facilitates influenza A viral immune escape by restricting TRIM25-mediated K63-linked RIG-I ubiquitination. iScience 2022;25:104607. [DOI: 10.1016/j.isci.2022.104607] [Reference Citation Analysis]
12 Fondevila F, Fernández-Palanca P, Méndez-Blanco C, Payo-Serafín T, Lozano E, Marin JJG, González-Gallego J, Mauriz JL. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers (Basel) 2021;13:5349. [PMID: 34771514 DOI: 10.3390/cancers13215349] [Reference Citation Analysis]
13 Lang L, Loveless R, Dou J, Lam T, Chen A, Wang F, Sun L, Juarez J, Qin ZS, Saba NF, Shay C, Teng Y. ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development. J Exp Clin Cancer Res 2022;41. [DOI: 10.1186/s13046-022-02274-9] [Reference Citation Analysis]